Bagsværd, 4 August 2026 – Financial report for the period 1 January 2026 to 30 June 2026                                                                                                                                             Financial performanceQ2 2026 reported sales increased by 3% at CER, with growth negatively impacted by a DKK 2.6 billion rebate provision reversal related to the 340B Drug Pricing Program in the US in Q2 2025. Q2 2026 adjusted sales increased by 7% at CER, driven by GLP-1 volume growth across geographies and favourable US rebate adjustments in the quarter. Q2 2026 reported operating profit decreased by 16% at CER, with growth negatively impacted by the US 340B rebate provision reversal in Q2 2025 as well as non-cash impairment charges of DKK 6.3 billion in Q2 2026 related to intangible pipeline assets,...

MONTREAL, Aug. 04, 2026 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (RSI) will be holding a conference call to discuss their 2026 third quarter results on Thursday, August 6th, 2026, at 8:00 a.m. (Eastern Time). The conference call will be chaired by Mr. Michael Walton, Chief Executive Officer and Mr. Jean-Sébastien Couillard, Chief Financial Officer. If you wish to participate, please dial 1-800-717-1738. A recording of the conference call will be accessible shortly after the conference, by dialing 1-888-660-6264, access code 36133#. This recording will be available until September 6, 2026. The discussion along with a presentation will be accessible through a webcast at the following address: https://onlinexperiences.com/Launch/QReg/ShowUUID=7DF66E07-DBBE-4110-8FCE-C43EC2AFF276&LangLocaleID=1033 For further information: Jean-Sébastien...

YANTAI, China, Aug. 04, 2026 (GLOBE NEWSWIRE) — Decent Holding Inc. (NASDAQ: DXST) (“Decent” or the “Company”), a technology-driven provider of wastewater treatment and community-based senior health and elderly care services in China, today announced its unaudited financial results for the six months ended April 30, 2026. Financial Highlights for the First Half of Fiscal Year 2026Total revenue increased by 238.0% to approximately $18.6 million, from approximately $5.5 million in the prior-year period, driven by significant growth in wastewater treatment services and contributions from the newly launched digital health and wellness business. Gross profit increased by 310.3% to approximately $6.2 million, from approximately $1.5 million in the prior-year period. Gross margin improved to 33.4% from 27.5% in the prior-year period. Net...

Second quarter revenue of $30M, +43% year-over-year growth; IFRS gross margin of 76.5% Second quarter usage fee revenue of $13.9M, 52.2% year-over-year growth First half revenue of $54.4M, +44% year-over-year growth; IFRS gross margin of 75.8% Second quarter IFRS and non-IFRS net income of $2.5M and $3.0M (or $3.8M exc. one-time expenses), versus IFRS and non-IFRS net income of $1.5M and $2.2M in the prior year period Generated $3.6M in cash in the second quarter Approximately 3,100 Sofwave systems sold to date and more than 975,000 Sofwave treatments administered since commercializationSAN CLEMENTE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the second quarter...

Achieved record total revenue, test volume and trailing twelve-month ASP Reduced net loss by nearly 30% and narrowed adjusted EBITDA loss to $0.1 million Increased full-year revenue guidance to $72 – $75 million CARLSBAD, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2026, and recent corporate updates.    Three Months Ended June 30,   Six Months Ended June 30,      2026       2025       2026       2025  Unaudited. In thousands, exceptASP data.    Revenue   $ 19,941     $ 17,202     $ 37,247     $ 32,700  Gross margin     61.3 %     60.4 %     60.2 %     59.7 %Operating expenses   $ 13,939     $ 13,025     $ 27,558     $ 25,513  Operating loss   $ (1,722 )   $ (2,630 )   $ (5,136 )   $ (5,995 )Net...

Improving Industrial Demand and Continued Focus on Strategic Initiatives Drive Results Managing Costs and Driving Gross Margin Improvement MARLBOROUGH, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2026.    Three Months Ended June 30,   Six Months Ended June 30,(In millions, except per share data and percentages)     2026       2025     Change     2026       2025     ChangeRevenue   $ 278.6     $ 250.7     11 %   $ 544.1     $ 478.5     14 %Gross margin     40.4 %     37.3 %         39.0 %     38.3 %    Operating income (loss)   $ 4.5     $ 0.1     NM   $ (3.2 )   $ 1.9     NMOperating margin     1.6 %     — %       (0.6 )%     0.4 %    Net income   $ 5.2     $ 6.6     (21 )%   $ 6.8     $ 10.4     (35 )%Earnings...

Completed in-licensing of ex-China rights to two potentially best-in-class compounds (NXP100 and NXP200) from Haisco Pharmaceutical Group (“Haisco”), transforming the company into a late-stage clinical development organization. The Company’s lead drug candidate, Ciprocopan (NXP100), a Complement Factor B inhibitor for once-daily, oral administration, was approved in China in July 2026 for the treatment of patients with PNH Previously Untreated with Complement Inhibitors. Completed follow-on offering in July 2026, raising $115M in gross proceeds. Transaction anchored by leading healthcare dedicated investors and extends cash runway into 1H 2029.FORT LEE, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company...

HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) (“Sysco” or the “company”) today announced financial results for its 13-week fourth fiscal quarter and its fiscal year ended June 27, 2026. Key financial results for the fourth quarter of fiscal year 2026 include the following (comparisons are to the same period in fiscal year 2025):Sales increased 4.7%; U.S. Foodservice volume increased 2.5%, U.S. local volume increased 2.6%; Gross profit increased 3.7% to $4.1 billion; Operating income increased 10.6% to $983 million, and adjusted operating income increased 4.1% to $1.1 billion1; Net earnings increased 3.8% to $551 million, and adjusted net earnings increased 2.5% to $734 million1; EBITDA increased 5.4% to $1.2 billion1, and adjusted EBITDA increased 4.7% to $1.3 billion1; EPS2 increased 4.5% to $1.15, and...

NINGBO, China, Aug. 04, 2026 (GLOBE NEWSWIRE) — PN Smart Energy Limited (“PN Smart” or the “Company”) (NASDAQ: PN), a global independent power producer (IPP) focused on the development of clean power stations, critical energy materials, and intelligent energy infrastructure, announced its financial results for the six months ended March 31, 2026. Financial HighlightsTotal revenue increased 5.5% YoY to approximately $25.5 million for the six months ended March 31, 2026, compared to approximately $24.2 million in the prior-year period. International revenue surged 44.6% YoY to approximately $10.8 million, up from approximately $7.5 million, driven by global network expansion and new production capacity. Total assets grew 29.5% to approximately $58.9 million as of March 31, 2026 from approximately $45.5 million as of September 30,...

Second Quarter 2026 Financial HighlightsNet income of $113.8 million, or $0.47 per fully diluted share, compared to $111.1 million and $0.46 in the prior quarter and $91.4 million, or $0.41 per fully diluted share in the prior year quarter Net interest income of $212.8 million, reflecting a net interest margin (“NIM”) of 4.40% compared to 4.32% in the prior quarter and 4.26% in the prior year quarter Average total loans held for investment of $11.6 billion, quarterly increase of $0.1 billion, or 3.9% annualized, from the prior quarter Average total deposits of $15.4 billion, an increase of $0.4 billion or 3.0% from prior year quarter Return on average assets (“ROAA”) of 2.24% Efficiency ratio of 46.5% and efficiency ratio (FTE)1 of 46.1%JEFFERSON CITY, Mo., Aug. 04, 2026 (GLOBE NEWSWIRE) — Central Bancompany, Inc. (Nasdaq:...